melatoninFinding
Melatonin has no detected effect on malondialdehyde (circulating)
no difference foundModerate evidenceFinding
01 · The sentence it was drawn from
“Also, the MLT group demonstrated marginal reduction in MDA compared to placebo group (F = 3.046, p = 0.092, partial η2 = 0.095), revealing a trend towards decreased oxidative stress that did not reach statistical significance.”
melatonin
Malondialdehyde (circulating)
no difference found
- Who
- children on chronic haemodialysis; primary endpoint, ANCOVA adjusted for baseline MDA and antihypertensive use; serum MDA by ELISA
- Dose studied
- 5 mg oral melatonin once daily 1 h before bedtime for 12 weeks
Moderate evidencePMID 41565787 · 2026
02 · The study
- Study
- RCT
- Duration
- 3 months
Evidence, by strength
- strong
- moderatethis finding
- limited
- very limited
- insufficient
03 · The paper
Scientific reports2026PMID 41565787doi 10.1038/s41598-025-34264-0
A later check left this paper out of the papers counted for melatonin; the finding stays because it matches the quoted sentence.
04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M3R2JMQ36NNA29QDT7N5TJ4B